Life Sciences & Biomedicine Ophthalmology Science & Technology
Purpose. To provide a current perspective on the management of convergence insufficiency (CI) in children by summarizing the findings and discussing the clinical implications from three recent randomized clinical trials in which we evaluated various treatments for children with symptomatic Cl. We then present an evidence-based treatment approach for symptomatic Cl based on the results of these trials. Finally, we discuss unanswered questions and suggest directions for future research in this area.
Methods. We reviewed three multi-center randomized clinical trials comparing treatments for symptomatic (CI) in children 9 to 17 years old.(one study 9 to 18 years old). Two trials evaluated active therapies for Cl. These trials compared the effectiveness of office-based vergence/accommodative therapy, office-based placebo therapy, and home-based therapy [pencil push-ups alone (both trials), home-based computer vergence/accommodative therapy, and pencil push-ups (large-scale study)]. One trial compared the effectiveness of base-in prism reading glasses to placebo reading glasses. All studies included well-defined criteria for the diagnosis of Cl, a placebo group, and masked examiners. The primary outcome measure was the Convergence Insufficiency Symptom Survey score. Secondary outcomes were near point of convergence and positive fusional vergence at near.
Results. Office-based vergence/accommodative therapy was significantly more effective than home-based or placebo therapies. Base-in prism reading glasses were no more effective than placebo reading glasses for the treatment of symptomatic Cl in children.
Conclusions. Recent clinical trials showed that office-based vision therapy was successful in about 75% of patients (resulting in normal or significantly improved symptoms and signs) and was the only treatment studied which was more effective than placebo treatments for children with symptomatic Cl. Eye care providers who do not currently offer this treatment may consider referring these patients to a doctor who provides this treatment or consider expanding the treatment options available within their practice to manage this condition. (Optom Vis Sci 2009;86:420-428)
Michael Rouse - So Calif Coll Optometry, Optometry Study Ctr Vis Therapy, Fullerton, CA USA
Marjean Taylor Kulp - The Ohio State University
Susan Cotter - So Calif Coll Optometry, Ctr Vis Res, Fullerton, CA USA
Richard Hertle - University of Pittsburgh
G. Lynn Mitchell - The Ohio State University
Publication Details
Optometry and vision science, v 86(5), pp 420-428
Publisher
Lippincott Williams & Wilkins
Number of pages
9
Grant note
National Eye Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)
U10EY014713 / NATIONAL EYE INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)
National Institutes of Health, Department of Health and Human Services; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Resource Type
Journal article
Language
English
Academic Unit
Pennsylvania College of Optometry (PCO)
Web of Science ID
WOS:000265810800003
Scopus ID
2-s2.0-67651173078
Other Identifier
991021900610604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: